Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contribution of "Genuine Microglia" to Alzheimer's Disease Pathology.
Hashioka S, Inoue K, Otsuki K, Hayashida M, Wake R, Kawano N, Takeshita H, Inagaki M. Hashioka S, et al. Front Aging Neurosci. 2022 Mar 24;14:815307. doi: 10.3389/fnagi.2022.815307. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35401156 Free PMC article. No abstract available.
Minocycline improves recognition memory and attenuates microglial activation in Gunn rat: a possible hyperbilirubinemia-induced animal model of schizophrenia.
Liaury K, Miyaoka T, Tsumori T, Furuya M, Hashioka S, Wake R, Tsuchie K, Fukushima M, Limoa E, Tanra AJ, Horiguchi J. Liaury K, et al. Among authors: hashioka s. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:184-90. doi: 10.1016/j.pnpbp.2013.12.017. Epub 2014 Jan 2. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24389395
The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J. Araki T, et al. Among authors: hashioka s. Int J Geriatr Psychiatry. 2014 Sep;29(9):881-9. doi: 10.1002/gps.4074. Epub 2014 Jan 17. Int J Geriatr Psychiatry. 2014. PMID: 24436135 Clinical Trial.
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).
Miyaoka T, Furuya M, Horiguchi J, Wake R, Hashioka S, Tohyama M, Mori N, Minabe Y, Iyo M, Ueno S, Ezoe S, Murotani K, Hoshino S, Seno H. Miyaoka T, et al. Among authors: hashioka s. Psychopharmacology (Berl). 2015 Jan;232(1):155-64. doi: 10.1007/s00213-014-3645-8. Epub 2014 Jun 13. Psychopharmacology (Berl). 2015. PMID: 24923986 Clinical Trial.
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial.
Miyaoka T, Furuya M, Horiguchi J, Wake R, Hashioka S, Thoyama M, Murotani K, Mori N, Minabe Y, Iyo M, Ueno S, Ezoe S, Hoshino S, Seno H. Miyaoka T, et al. Among authors: hashioka s. Evid Based Complement Alternat Med. 2015;2015:201592. doi: 10.1155/2015/201592. Epub 2015 Apr 14. Evid Based Complement Alternat Med. 2015. PMID: 25954314 Free PMC article.
Analysis of oxidative stress expressed by urinary level of biopyrrins and 8-hydroxydeoxyguanosine in patients with chronic schizophrenia.
Miyaoka T, Ieda M, Hashioka S, Wake R, Furuya M, Liaury K, Hayashida M, Tsuchie K, Arauchi R, Araki T, Shioji I, Ezoe S, Inoue K, Yamaguchi T, Horiguchi J. Miyaoka T, et al. Among authors: hashioka s. Psychiatry Clin Neurosci. 2015 Nov;69(11):693-8. doi: 10.1111/pcn.12319. Epub 2015 Jul 14. Psychiatry Clin Neurosci. 2015. PMID: 25975810 Free article.
94 results